Overall rank by patents
#26,411
of 50,000 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
The verdict
According to USPTO PatentsView, Grifols ranks #26,411 of 50,000 tracked US assignees by granted-patent volume, with 10 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R26411 · US Corporation #26,411 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Grasslanz Technology Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Focal Jmlab · near
24 score
Grifols Therapeutics · this assignee
24 score
Picote Solutions · near
24 score
Tuf-tite · near
24 score
Bluebonnet Foods · near
24 score
3D Lighting Innovati… · lowest
7 score
What this shows Grifols's Innovation Score is 23.6/100 (top 88% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Grifols Therapeutics Inc. is a focused PatentsView assignee: 7 CPC subclasses with 50% of grants classified under C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). Peak complete grant year is 2016 (3 grants) versus a trough of 2 in 2015. By volume, Grifols sits between Grasslanz Technology Limited and Guardhat, Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Grasslanz Technology Limited
10 patents
Green Bay Packaging, Inc.
10 patents
GreenOnyx LTD
10 patents
Greyfin LLC
10 patents
Gritstone Bio, Inc.
10 patents
Groundspeak, Inc.
10 patents
Guangzhou Lianrou Machinery & Equipment Co., Ltd.
10 patents
Guardhat, Inc.
10 patents
Grifols Therapeutics Inc.
10 patents
What this shows Grifols holds 10 patents at rank #26,417, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #26,417 in granted patent volume.
Other assignees with the most granted patents in Grifols's primary technology class.
Two PlainPatent-derived peer sets for Grifols, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (24 here).
Grifols's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
24 Top 88% higher than 12% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 20.0% |
| 2016 | 3 | 30.0% |
| 2017 | 2 | 20.0% |
| 2018 | 3 | 30.0% |
Top 7 of 7 technology areas
Overall rank by patents
#26,411
of 50,000 tracked assignees
23.6 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.